160 related articles for article (PubMed ID: 38477665)
1. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
Gignac T; Trépanier G; Pradeau M; Morissette A; Agrinier AL; Larose É; Marois J; Pilon G; Gagnon C; Vohl MC; Marette A; Carreau AM
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E616-E625. PubMed ID: 38477665
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
3. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans.
Kratz M; Marcovina S; Nelson JE; Yeh MM; Kowdley KV; Callahan HS; Song X; Di C; Utzschneider KM
Am J Clin Nutr; 2014 Jun; 99(6):1385-96. PubMed ID: 24740208
[TBL] [Abstract][Full Text] [Related]
4. Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels.
Marini MA; Frontoni S; Succurro E; Arturi F; Fiorentino TV; Sciacqua A; Hribal ML; Perticone F; Sesti G
PLoS One; 2013; 8(10):e77440. PubMed ID: 24194886
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885
[TBL] [Abstract][Full Text] [Related]
7. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
9. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
10. Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
Lamprinou A; Willmann C; Machann J; Schick F; Eckstein SS; Dalla Man C; Visentin R; Birkenfeld AL; Peter A; Stefan N; Häring HU; Fritsche A; Heni M; Wagner R
Metabolism; 2021 Jun; 119():154776. PubMed ID: 33862045
[TBL] [Abstract][Full Text] [Related]
11. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
12. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Henninger J; Hammarstedt A; Rawshani A; Eliasson B
BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Osei K; Gaillard T; Schuster D
Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
[TBL] [Abstract][Full Text] [Related]
14. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
16. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver.
Xie Y; Li S; Chen R; He R; Qian L; Zou J; Luo Y; Zhang Y; Ji M; Liu Y
Metab Syndr Relat Disord; 2022 Oct; 20(8):451-458. PubMed ID: 36260098
[No Abstract] [Full Text] [Related]
17. Sfrp5 associates with beta-cell function in humans.
Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C
Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
19. Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction.
Spadaro L; Alagona C; Palermo F; Piro S; Calanna S; Parrinello G; Purrello F; Rabuazzo AM
Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):206-12. PubMed ID: 20096546
[TBL] [Abstract][Full Text] [Related]
20. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
